Innovative EyewearLUCY -3.81%56 Days Payable is 154.55 as of Mar. 2026, which is 15% above its 10-year median of 134.69. GuruFocus rates LUCY with a GF Score™ of 56/100 and a GF Value™ of $1.82 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Innovative Eyewear ranks better than 68.05% on this metric.
The historical rank and industry rank for Innovative Eyewear's Days Payable or its related term are showing as below:
LUCY'
s Days Payable Range Over the Past 10 Years
Min: 73.27 Med: 134.69 Max: 251.55
Current: 106.78
During the past 7 years, Innovative Eyewear's highest Days Payable was 251.55. The lowest was 73.27. And the median was 134.69.
LUCY's Days Payable is ranked better than 68.05% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs LUCY: 106.78
Innovative Eyewear's Days Payable
declined
from Mar. 2025 (196.15) to Mar. 2026 (154.55).
It may suggest that Innovative Eyewearaccelerated paying its suppliers.
Innovative Eyewear Days Payable Related Terms
Innovative Eyewear Days Payable Historical Data
* Premium members only.
The historical data trend for Innovative Eyewear's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Innovative Eyewear's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Innovative Eyewear Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Innovative Eyewear's Days Payable distribution charts can be found below:
* The bar in red indicates where Innovative Eyewear's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Innovative Eyewear's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Innovative Eyewear (LUCY) has a Days Payable of 154.55 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Innovative Eyewear and its competitors. This is 15% above median its historical median of 134.69. Over the past decade, Innovative Eyewear's Days Payable has ranged from 73.27 to 251.55. According to the industry distribution chart, Innovative Eyewear ranks #254 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 31.9%.
Is Innovative Eyewear's Days Payable too high?
Innovative Eyewear's current Days Payable of 154.55 is 15% above median its 10-year median of 134.69. Over the past 10 years, this metric has ranged from a low of 73.27 to a high of 251.55. The Medical Devices & Instruments industry median Days Payable is 68.07. Innovative Eyewear's value of 154.55 is 127% above this industry median. Based on the distribution chart, Innovative Eyewear ranks #254 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Innovative Eyewear has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Innovative Eyewear's Days Payable compare to NXGL and CBSC?
According to the Medical Devices & Instruments industry distribution chart, Innovative Eyewear ranks #254 out of 795 companies for Days Payable. This puts Innovative Eyewear in the upper half of its industry. The industry median Days Payable is 68.07. Innovative Eyewear's value of 154.55 is 127% above this benchmark. Historically, Innovative Eyewear's own Days Payable has ranged from 73.27 to 251.55 over the past decade. While the company's 10-year median is 134.69 vs. the industry median of 68.07, Innovative Eyewear has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Innovative Eyewear's current Days Payable of 154.55 is 127% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Innovative Eyewear and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Innovative Eyewear's current Days Payable is 154.55, which is 15% above median its own 10-year median of 134.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovative Eyewear stock overvalued right now?
Based on GuruFocus' analysis, Innovative Eyewear (LUCY) is currently considered Possible Value Trap. The stock's GF Value™ is $1.82, compared to a current price of $0.76 — trading 58.2% below its estimated fair value. The current Days Payable is 154.55, which is 15% above median its 10-year median of 134.69 and 127% above the Medical Devices & Instruments industry median of 68.07. Innovative Eyewear's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Innovative Eyewear (LUCY), the current Days Payable is 154.55 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Innovative Eyewear (LUCY) Overvalued in 2026?
Based on GuruFocus' analysis, Innovative Eyewear stock appears to be undervalued.
The current stock price of $0.76 is trading 58.2% below its estimated GF Value™ of $1.82.
GuruFocus considers Innovative Eyewear to be Possible Value Trap.
Key valuation signals for LUCY:
Days Payable: 154.55 (15% above median its 10-year median of 134.69)
GF Value™: $1.82 vs. price of $0.76 (58.2% below fair value)
Industry Position: 127% above the Medical Devices & Instruments median (#254 of 795)
No single metric tells the full story. See the LUCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok. The firm derive substantially all of its revenue from the sale of smart glasses and custom lenses.
56GF Score
Get the complete analysis for LUCY
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LUCY has been successfully added to your 
